Articles tagged with Vaccination
The COVID-19 pandemic led to staggering income losses and food insecurity across nine countries in Africa, Asia, and Latin America. The research found that households reported financial losses, reduced meals, and closed schools may lead to delayed development and health consequences for children.
Researchers analyzed 851,199 listings from 30 dark web marketplaces between Jan 2020 and Nov 2020 to identify COVID-19 related products. DarkBay/DBay emerged as a prominent platform offering COVID-19 specific listings.
Researchers have developed three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, which can be used to test vaccines and therapies. The studies found that cynomolgus macaques, rhesus macaques, and African green monkeys developed disease similar to mild acute respiratory disease in humans.
Researchers analyzed 851,199 listings from 30 dark web marketplaces, identifying 788 COVID-19 related products. The study highlights the importance of monitoring DWMs due to vaccine shortages and potential health risks.
Researchers have created an experimental vaccine that has shown promise in blunting the deadly effects of synthetic opioids like fentanyl and carfentanil. In early tests, the vaccine demonstrated significant reduction in fatal respiratory effects, offering hope for a new treatment approach to combat the opioid crisis.
A new Ontario study found that dialysis patients are almost 4 times more likely to die from COVID-19 compared to uninfected counterparts. The researchers recommend prioritizing these patients for vaccination and implementing infection control measures, including paid sick leave and regular testing.
Researchers discovered SARS-CoV-2 mutates by deleting small bits of its sequence, evading neutralizing antibodies. This pattern repeats itself in emerging variants like B.1.1.7, highlighting the need for multiple approaches to combat the virus.
The AAVCOVID vaccine program has received a $2.1 million grant to support phase I clinical trials overseas, with single-dose vaccines that can be stored at room temperature for up to one month. This stability could enable distribution in regions with limited infrastructure.
The BioNTech-Pfizer COVID-19 vaccine retains its immune protection against the B.1.1.7 viral variant, suggesting it can prevent 'escape' from vaccine-mediated protection. The study's findings support the use of mRNA-based vaccine technology for adapting to new virus strains.
The essay argues that politicization of biomedical science in the US led to a surge in cases and deaths, despite evidence-based safety measures. Dr. Hotez calls for a national response task force to combat anti-science activities and protect public health.
A new study estimates that vaccination against 10 major pathogens will have prevented 69 million deaths in low-income and middle-income countries between 2000 and 2030. Vaccination programs are expected to reduce mortality from these diseases by 72% for those born in 2019, with the greatest impact on children under five.
A new modelling study estimates that without vaccination, mortality in children under five would be 45% higher in low-income and middle-income countries. Vaccination has prevented 69 million deaths between 2000-2030.
The German National Academy of Sciences Leopoldina hosts an international virtual panel discussion on COVID-19 vaccination challenges. Experts will address issues like equitable global allocation and vaccine effectiveness. The event aims to promote scientific dialogue among the international community.
Pregnant and breastfeeding individuals should be offered COVID-19 vaccines based on ethical principles, considering individual autonomy and risk of severe illness. Although no adverse effects have been observed in vaccinated participants, those at high risk of severe COVID-19 should prioritize vaccination to protect themselves and others.
A study found that over half of Ebola survivors experienced a rapid increase in antibody levels around 200 days after recovery, followed by decline, indicating potential long-term virus persistence.
The American College of Physicians and Annals of Internal Medicine hosted a third virtual COVID-19 vaccine forum, discussing the allocation and distribution of available vaccines. Researchers also published an observational study finding that early therapeutic anticoagulation in critically ill patients with COVID-19 did not affect surv...
Researchers warn that emerging strains threaten vaccine effectiveness, urging continued vaccination efforts and proper public health policies. Stronger action now is necessary to stop the evolution and spread of more virulent virus strains.
Research suggests that non-steroidal anti-inflammatory drugs (NSAIDs) can dampen the immune response to SARS-CoV-2 infection. This could have implications for COVID-19 treatment and vaccination strategies. The findings also highlight the need for further evaluation of NSAID use during natural infections and vaccinations.
Researchers found that rhesus macaques infected with SARS-CoV-2 developed protective immune responses, including the production of antibodies and Th1 cells. These findings suggest that vaccines inducing durable protective immunity against SARS-CoV-2 may stimulate robust germinal center responses.
A recent study published in the British Journal of Psychology found that people are more likely to follow Covid-19 restrictions based on their close circle's behavior rather than their own principles. The researchers discovered that the best predictor of compliance was how much one's close friends and family were following the rules.
A review of Centers for Disease Control and Prevention reports confirms cases of anaphylactic reactions after Pfizer-BioNTech COVID-19 vaccine administration. The study highlights the importance of monitoring vaccine recipients for potential allergic reactions.
A new study suggests that prioritizing older adults for COVID-19 vaccination can save the most lives, with an estimated reduction of 23% in mortality rates over three months. The research also highlights the importance of a fast vaccine rollout and other public health measures to control the spread of the virus.
A new Commentary in Preventive Medicine suggests financial incentives could promote high levels of COVID-19 vaccine adherence, crucial for achieving herd immunity. Strong evidence from controlled trials supports the efficacy of incentivizing vaccine adherence, including a 7-fold increase in adherence with modest financial incentives.
A new model simulates the spread of COVID-19 in a small town, finding that prioritizing vaccination of high-risk individuals has limited impact. Social distancing and mask-wearing remain crucial to fighting the pandemic.
A recent study found that mortality rates decreased among critically ill COVID-19 patients over time. In contrast, experts from NIAID emphasized the importance of using data to encourage vaccine uptake. Meanwhile, a hospital essay describes a Ransomware attack during the pandemic, highlighting the challenges faced by healthcare profess...
The NIH highlights seven COVID-19 vaccines with promising data on safety and efficacy, while acknowledging remaining unknowns. The commentary emphasizes the need for healthcare providers to strongly encourage vaccination, particularly as rare side effects may emerge in large populations.
Researchers at the University of Sydney have developed a novel method to rapidly synthesize safe vaccines using protein-based immunization. The approach demonstrated strong immune response in mice against tuberculosis and has potential applications for respiratory diseases, including COVID-19.
A recent redesign of a dog vaccination campaign in Blantyre city, Malawi, reduced the cost and time associated with rabies prevention by leveraging real-time data collection. The campaign vaccinated over 70% of local dogs using a combination of fixed locations and door-to-door vaccinations.
A new poll finds that 45% of adults aged 65-80 and 42% of all adults aged 50-80 lack online medical accounts, which could hinder COVID-19 vaccine scheduling. Patient portals can help bridge this gap, especially for those with lower incomes, education levels, or who require assistance setting up accounts.
Researchers at the University of Wisconsin-Madison have developed a tool to help prioritize vaccine distribution among people who share similar risks due to their jobs. The algorithm considers both age and socioeconomic status to identify those at greater risk of severe COVID-19 complications.
Scientific scepticism may be reinforced in the UK due to the rapid approval of COVID vaccines, warns Professor John Ashton. The former director of public health highlights the potential breakdown of trust between the government and the public over vaccination objections.
A study found nearly half of summer camps didn't have official policies requiring campers be vaccinated, with only 39% mandating staffers vaccinations. Camps allow unvaccinated children with nonmedical exemptions to attend programs.
A new study suggests that COVID-19 vaccines may be less effective in individuals with depression, stress, loneliness, or poor health behaviors. Engaging in exercise and getting a good night's sleep before vaccination can help boost the immune response.
Researchers predict SARS-CoV-2 will become a mild childhood disease, with older individuals providing immune protection against severe illness. The model suggests that widespread vaccination may not be necessary if primary infections are mild in children, but should continue if they become severe.
The Academy of Breastfeeding Medicine suggests that lactating women discuss the risks and benefits of COVID-19 vaccination with their healthcare provider. The ABM statement is based on biological plausibility and expert opinion, considering there are no clinical data on vaccine safety in nursing mothers.
The COVID-19 pandemic has accelerated the development of vaccines using advanced technologies like reverse vaccinology and synthetic biology. These innovations could help address other pressing health challenges such as antimicrobial resistance and cancer.
Researchers at Umeå University have made a significant discovery about the diarrhea virus, revealing its ability to survive acidic stomach environments and infect intestines. This understanding could lead to the development of new vaccines, potentially given in edible form, and has implications for tackling diseases like COVID-19.
Recent surveys indicate a fluctuating willingness to be vaccinated, with 60% willing and 51% unwilling; experts propose 12 strategies, including analogy and explanation, to boost vaccine uptake and achieve 100% follow-through.
A new study suggests that shortening the COVID-19 infectious period by half a day could avert up to 1.4 million cases and over 99,000 hospitalizations, saving $209.5 billion in direct medical costs. Expanding treatment to 75% of infected individuals could avert 29.7 million cases and save $856 billion.
Researchers developed an mRNA vaccine that restored tolerance to self-proteins in mice with autoimmune encephalomyelitis, a mouse model for multiple sclerosis. The vaccine suppressed immune responses and promoted regulatory T cells to control the disease.
Researchers at Swansea University have received £230,000 to develop a smart vaccine device that delivers the COVID-19 vaccine and measures its efficacy through monitoring biomarkers in the skin. The device uses microneedles for minimally invasive delivery and offers a personalized vaccination approach.
Researchers suggest that single-dose vaccines may offer greater population benefit due to the speed-versus-efficacy tradeoff. Alternative dose allocation strategies also improve benefits by vaccinating more people sooner while maintaining scheduling for second doses.
A recent study found that nearly 40% of Facebook posts about the HPV vaccine amplified perceived health risks, leading to a false perception of the vaccine's safety. Monique Luisi, an expert in health communication, believes this phenomenon can inform the COVID-19 vaccine rollout and distribution.
Experts discuss microbial-based solutions to combat COVID-19, including vaccine candidates and production platforms. The webinar explores learnings from vaccine development, innovative approaches to address systemic inflammation.
The mRNA-1273 vaccine demonstrated effectiveness in preventing severe COVID-19, with no safety concerns or evidence of enhanced respiratory disease. The trial enrolled over 30,000 participants and showed a significant reduction in symptomatic cases among those who received the vaccine.
The Moderna COVID-19 vaccine has demonstrated a 94.1 percent efficacy in preventing symptomatic COVID-19 infections and severe illness, according to the results of the ongoing phase 3 clinical trial. The study enrolled over 30,000 participants and found that cases of severe COVID-19 occurred only in those who received the placebo.
Researchers at the University of Zurich have developed a genetic engineering method to prevent Toxoplasma gondii parasite production, which causes toxoplasmosis. The new technique uses CRISPR-Cas9 gene editing scissors to switch off essential genes responsible for oocyst formation without leaving unwanted traces.
Researchers found that people infected with COVID-19 retain immunity for at least 8 months through virus-specific memory B cells. This discovery alleviates concerns about vaccine efficacy and provides real hope for long-term protection against the virus.
The American College of Physicians (ACP) hosted a virtual COVID-19 Vaccine Forum II to address barriers to optimal vaccine uptake. Panelists emphasized the need for comprehensive public health communications campaigns to refute misinformation and build trust among disproportionately affected minority communities.
A recent study found that combining mandatory mask-wearing policies with extensive social distancing can prevent most COVID-19 cases on college campuses, with routine testing also showing high effectiveness. However, the cost of testing may be a barrier for some colleges and universities.
The Advanced Photon Source (APS) has been instrumental in the development of COVID-19 vaccines, allowing for rapid progress through genetic mutations that increase effectiveness. Scientists used APS ultrabright X-ray beams to illuminate virus structures and design vaccine techniques, drugs, and treatments.
A recent national study found that factors such as perceived importance of others, confidence to wear a face covering, and personal importance of use positively associated with intention to wear a face covering. The study suggests that messaging strategies targeting individual intentions and social norms may be more effective than focu...
A recent study assessed the acceptability of COVID-19 vaccine mandates in the US public, revealing mixed attitudes towards mandates. The study found that while some individuals strongly supported vaccine mandates, others were more hesitant or opposed.
A national vaccine strategy is crucial to defeating COVID-19, according to Columbia University's Mailman School of Public Health. The school recommends setting realistic expectations on vaccine effectiveness and promoting universal health coverage for vulnerable populations.
Researchers at Nationwide Children's Hospital found a 10% drop in MMR vaccine uptake among children aged 16 months. The study highlights the need for preventive care visits during the pandemic, despite safety concerns.
Researchers achieved rapid development of effective vaccines against COVID-19, highlighting the collaboration between scientists and governments. However, this unprecedented speed revealed alarming fissures between science and policy makers.
Scientists at Scripps Research have developed a vaccine that can deactivate the effects of synthetic cannabinoids in rodents, sequestering drug molecules before they interact with the central nervous system. The approach worked in models simulating smoking and vaping, a common method of use for these drugs.
Research highlights individual-level barriers to COVID-19 vaccination in individuals with severe mental illness, including stigma and lack of access to healthcare. The study identifies system-level solutions, such as improving mental health services and increasing vaccine accessibility, to address these gaps.
Scientists successfully produced C-nucleosides, the basic building blocks of RNA, using an enzyme called YeiN, offering a more efficient and eco-friendly alternative to chemical synthesis. This breakthrough has implications for the production of RNA-based therapeutic products, such as vaccines.
For global success, vaccines must prevent all three: infection, disease progression, and transmission. The authors emphasize prioritizing vulnerable populations and healthcare workers before the wider population.